Mortality and morbidity 1 year after stopping a remote patient management intervention: extended follow-up results from the telemedical interventional management in patients with heart failure II (TIM-HF2) randomised trial
Friedrich Koehler(Charité - Universitätsmedizin Berlin), Stefan D. Anker(German Centre for Cardiovascular Research), Sandra Prescher(Charité - Universitätsmedizin Berlin), Bridget‐Anne Kirwan, Eik Vettorazzi(University Medical Center Hamburg-Eppendorf), Sebastian Spethmann, Henryk Dreger(Humboldt-Universität zu Berlin), G. Fiss(Charité - Universitätsmedizin Berlin), Christian Butter, Stephan von Haehling(University of Göttingen), Karl Wegscheider(Universität Hamburg), Martin Halle(Institute for Sports Medicine), Judith Schleder(Charité - Universitätsmedizin Berlin), Oliver Deckwart(Charité - Universitätsmedizin Berlin), Roland Prondzinsky(Merseburg University of Applied Sciences), Christiane E. Angermann(Universitätsklinikum Würzburg), Stefan Störk(Berlin-Brandenburger Centrum für Regenerative Therapien), Susanne Lezius(Zimmer Biomet (Germany)), Verena Stangl(German Centre for Cardiovascular Research), Christian Zugck, Kerstin Koehler(Charité - Universitätsmedizin Berlin), Magdalena Koehler(TUM Klinikum), Volker Moeller(Charité - Universitätsmedizin Berlin), Karl Stangl(Humboldt-Universität zu Berlin), Sebastian Winkler(Unfallkrankenhaus Berlin)
Cited by 61
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2020|2.6k
The Seattle Heart Failure Model
|Circulation|2006|2k
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease
|European Heart Journal|2020|1.8k